Carol Hill, PhD

Duke Clinical Research Institute
Durham, North Carolina, United States

Disclosure(s): Glaxo SmithKline: Retirement Health, Cash Balance Plan, Stocks/Bonds (Public Company)

Presentation(s):

• 84 - Improving Traditional Registrational Trial Endpoints: Development and Application of a Desirability of Outcome Ranking (DOOR) Endpoint for Acute Bacterial Skin and Skin-Structure Infections

  Thursday, October 17, 2024
  11:00 AM – 11:15 AM US PT

• 101 - Patients with Carbapenem-resistant Klebsiella aerogenes and Enterobacter cloacae complex Colonization or Infection Have Different Baseline Characteristics but Similar Mortality and Clinical Outcomes

  Thursday, October 17, 2024
  11:15 AM – 11:30 AM US PT